Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX: 13) today announces that the supplemental New Drug Application for ORPATHYS® (savolitinib) has been granted approval by the China National Medical Products ...
UNG follows the section 508 Standards and WCAG 2.0 for web accessibility. If you require this content in another format, please send an email to the ADA Coordinator. Use of military-themed imagery ...